(Q33751731)

29 July 2017

1 reference

title

Extracellular proteolysis: new paradigms for an old paradox (English)

1 reference

29 July 2017

1 reference

C A Owen

1

1 reference

29 July 2017

E J Campbell

series ordinal

2

1 reference

29 July 2017

publication date

1 October 1999

1 reference

29 July 2017

published in

Translational Research

1 reference

29 July 2017

volume

134

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

341-351

1 reference

Neutrophil collagenase in sputum from patients with cystic fibrosis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

The regulation of neovascularization of matrix metalloproteinases and their inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

The fibrinolytic system in neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Human plasma proteinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Inactivation of bronchial mucous proteinase inhibitor by cigarette smoke and phagocyte-derived oxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Cigarette Smoking Induces Functional Antiprotease Deficiency in the Lower Respiratory Tract of Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Functional alpha 1-protease inhibitor in the lower respiratory tract of cigarette smokers is not decreased

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Granulocyte elastase-mediated proteolysis of alpha 1-antitrypsin in cystic fibrosis bronchopulmonary secretions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Inactivation of human α1-proteinase inhibitor by thiol proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Different Susceptibility of Elastase Inhibitors to Inactivation by Proteinases fromStaphylococcus aureusandPseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Increased proteolytic cleavage of alpha 1-antitrypsin (alpha 1-proteinase inhibitor) in knee-joint synovial fluid from patients with rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Proteolytic inactivation of alpha 1-antitrypsin and alpha 1-antichymotrypsin by neutrophils in arthritic joints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Phagocytosing macrophages exclude proteins from the zones of contact with opsonized targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Extracellular proteolysis of fibronectin by neutrophils: characterization and the effects of recombinant cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Glomerular vascular cell adhesion molecule-1 expression in renal vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

TIMP-2 mediates cell surface binding of MMP-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Membrane proteases: roles in tissue remodeling and tumour invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Metalloproteinase domain structure, cellular invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Binding of gelatinases A and B to type-I collagen and other matrix components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Immunolocalization of elastase in human emphysematous lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Receptor-mediated binding of leukocyte elastase by chondrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Interference of cartilage surface with interaction of granulocyte elastase with alpha 1-proteinase inhibitor. An in vitro model of enzyme inhibition in the joint space

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Apoptosis in resolution of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Potentiative effects of neutral proteinases in an inflamed lung: relationship of neutrophil procollagenase (proMMP-8) to plasmin, cathepsin G and tryptase in bronchiectasis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Cathepsin G and elastase in synovial fluid and peripheral blood in reactive and rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Collagenase in synovitis of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Nonisotropic enzyme--inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Alpha 1 antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Oxidation-resistant variants of recombinant antileucoprotease are better inhibitors of human-neutrophil-elastase-induced emphysema in hamsters than natural recombinant antileucoprotease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Neutrophil elastase inhibitors, SC-37698 and SC-39026, reduce endotoxin-induced lung dysfunction in awake sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Effect of a synthetic leukocyte elastase inhibitor on thrombin-induced pulmonary edema in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

Mechanisms of neutrophil-induced parenchymal cell injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990148-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-2143(99)90148-8

1 reference

29 July 2017

1 reference